Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-023-02427-z, published online 24 June 2023. In the version of the article initially published, there were errors in Fig. 3d. The panel has now been corrected in the HTML and PDF versions of the article, and the original and revised versions can be seen below as Fig. 1. (Figure presented.) Original and revised Fig. 3d.